These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 33067537)
1. Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment. Arrigo A; Calamuneri A; Bordato A; Aragona E; Pierro L; Bandello F; Battaglia Parodi M Sci Rep; 2020 Oct; 10(1):17583. PubMed ID: 33067537 [TBL] [Abstract][Full Text] [Related]
2. Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH. Chan CK; Mein CE; Glassman AR; Beaulieu WT; Calhoun CT; Jaffe GJ; Jampol LM; MacCumber MW; Maguire MG; Maturi RK; Salehi-Had H; Rofagha S; Sun JK; Martin DF; Ophthalmology; 2021 Nov; 128(11):1592-1603. PubMed ID: 33989683 [TBL] [Abstract][Full Text] [Related]
3. Vitreomacular traction in diabetic retinopathy. Hsieh YT; Yang CM Jpn J Ophthalmol; 2024 Jan; 68(1):12-18. PubMed ID: 38001367 [TBL] [Abstract][Full Text] [Related]
4. NATURAL COURSE OF VITREOMACULAR TRACTION IN EYES WITH DIABETIC RETINOPATHY AND FACTORS ASSOCIATED WITH SPONTANEOUS RELEASE. Garip R; Çınar AK; Çınar AC; Gürlü V Retina; 2021 Aug; 41(8):1668-1674. PubMed ID: 33394961 [TBL] [Abstract][Full Text] [Related]
5. Effect Of Intravitreal Perfluoro Propane (C3f8) In The Management Of Symptomatic Vitreomacular Traction. Gardezi SM; Gul K; Batool M; Bodla AA J Ayub Med Coll Abbottabad; 2023; 35(3):367-370. PubMed ID: 38404073 [TBL] [Abstract][Full Text] [Related]
6. PREDICTIVE FACTORS ASSOCIATED WITH THE VISUAL PROGNOSIS AFTER SURGERY FOR IDIOPATHIC VITREOMACULAR TRACTION. Qi B; Yang X; Yu Y; Zhang K; Wu X; Wang X; Jia Q; Feng X; Liu W Retina; 2024 Mar; 44(3):429-437. PubMed ID: 37883595 [TBL] [Abstract][Full Text] [Related]
7. Impact of phacoemulsification on posterior vitreous detachment formation in eyes with vitreomacular traction. Tieger MG; Vavvas DG Digit J Ophthalmol; 2023; 29(2):26-30. PubMed ID: 37727466 [TBL] [Abstract][Full Text] [Related]
8. REVISED PREDICTIVE BIOMARKER FOR OCRIPLASMIN THERAPY IN VITREOMACULAR TRACTION DISORDERS. Al-Nawaiseh S; Rickmann A; Seuthe AM; Al-Rimawi D; Viktor Stanzel B; Szurman P Retina; 2021 Dec; 41(12):2549-2555. PubMed ID: 34173361 [TBL] [Abstract][Full Text] [Related]
9. CLOSURE OF IDIOPATHIC FULL-THICKNESS MACULAR HOLE AFTER INTRAVITREAL C3F8 INJECTION WITHOUT VITREOMACULAR TRACTION RELEASE: A CASE REPORT AND REVIEW OF LITERATURE. Fazel F; Rezaeian-Ramsheh A; Fazel M; Ahmadieh H Retin Cases Brief Rep; 2024 Jan; 18(1):77-79. PubMed ID: 35993722 [TBL] [Abstract][Full Text] [Related]